Zobrazeno 1 - 10
of 1 265
pro vyhledávání: '"Dihydroartemisinin–-piperaquine"'
Autor:
Jenna Hoyt, Hellen C. Barsosio, Isdorah A. Odero, Benson Omondi, Florence Achieng, Simon Kariuki, Jenny Hill, Jayne Webster
Publikováno v:
Malaria Journal, Vol 23, Iss 1, Pp 1-11 (2024)
Abstract Background Increasing resistance to sulfadoxine-pyrimethamine (SP) threatens the effectiveness of intermittent preventive treatment (IPTp) to prevent malaria in pregnancy. Dihydroartemisinin-piperaquine (DP) is the most promising candidate t
Externí odkaz:
https://doaj.org/article/a9a87298c5064146aadec2cea8ce6295
Autor:
Frederik Von Wowern, Geofrey Makenga, Sarah Wellmann Thomsen, Louise Wellmann Thomsen, Emma Filtenborg Hocke, Vito Baraka, Benjamin H. Opot, Daniel T.R. Minja, John P.A. Lusingu, Jean-Pierre Van-geertruyden, Helle Hansson, Michael Alifrangis
Publikováno v:
International Journal of Infectious Diseases, Vol 146, Iss , Pp 107102- (2024)
Objective: Intermittent Preventive Treatment of schoolchildren (IPTsc) is recommended by WHO as a strategy to protect against malaria; to explore whether IPTsc with dihydroartemisinin-piperaquine (DP) or artesunate-amodiaquine (ASAQ) cause a selectio
Externí odkaz:
https://doaj.org/article/abe4b30ff83545ca8a7b4b590155b130
Autor:
Ameyo Monique Dorkenoo, Marian Warsame, Essoham Ataba, Manani Hemou, Kossi Yakpa, Efoe Sossou, M’badi Mitigmsagou, Carmel Diwaba Teou, Emmanuelle Caspar, Laurence Ma, Koffi Edem Djadou, Tinah Atcha-Oubou, Charlotte Rasmussen, Didier Menard
Publikováno v:
Malaria Journal, Vol 23, Iss 1, Pp 1-17 (2024)
Abstract Background Artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) are the currently recommended first- and second-line therapies for uncomplicated Plasmodium falciparum infections in Togo. This study assessed the efficacy of th
Externí odkaz:
https://doaj.org/article/84a2192568d44c24b6bbd91ca6b741bc
Publikováno v:
Malaria Journal, Vol 23, Iss 1, Pp 1-12 (2024)
Abstract A Stakeholder engagement meeting on the implementation of post-discharge malaria chemoprevention (PDMC) in Benin, Kenya, Malawi, and Uganda was held in Nairobi, Kenya, on 27 September 2023. Representatives from the respective National Malari
Externí odkaz:
https://doaj.org/article/52fdd7cb1b8b4945b6930f29aafe9e75
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Esther Nthenya Muthoka, Kedir Usmael, Saba Mehari Embaye, Abigiya Abebe, Tigist Mesfin, Dorothy Kazembe, Mediha Ahmedin, Stella Namuganza, Monica Kahabuka, Mary Gorret Atim, Tsegahun Manyazewal
Publikováno v:
Malaria Journal, Vol 22, Iss 1, Pp 1-11 (2023)
Abstract Background Malaria infection during pregnancy is an important cause of maternal and infant mortality and morbidity with the greatest effect being concentrated in sub-Saharan Africa. In areas of moderate to high malaria transmission, the Worl
Externí odkaz:
https://doaj.org/article/e7af3f34aeba4acc9eb55b43a7cc9f1c
Autor:
Beatrice Gachie, Kelvin Thiong’o, Brenda Muriithi, Jean Chepngetich, Noah Onchieku, Jeremiah Gathirwa, Peter Mwitari, Gabriel Magoma, Daniel Kiboi, Francis Kimani
Publikováno v:
Malaria Journal, Vol 22, Iss 1, Pp 1-10 (2023)
Abstract Background Malaria remains a public health concern globally. Resistance to anti-malarial drugs has consistently threatened the gains in controlling the malaria parasites. Currently, artemether-lumefantrine (AL) and dihydroartemisinin-piperaq
Externí odkaz:
https://doaj.org/article/4da00f4fb9ea4c159c49df7c81a2c7b2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alberto Rizzo, Silvia Grosso, Ivano Faggion, Anna Gigantiello, Federica Salari, Fosca Niero, Simone Passerini, Chiara Mariani, Spinello Antinori, Maria Rita Gismondo
Publikováno v:
Travel Medicine and Infectious Disease, Vol 56, Iss , Pp 102671- (2023)
Externí odkaz:
https://doaj.org/article/014b44e7ad884acc95d11913bf28d84d
Autor:
Thandile Nkosi-Gondwe, Bjarne Robberstad, Robert Opoka, Dennis Kalibbala, Joseph Rujumba, Lufina Tsirizani Galileya, Pamela Akun, Winnie Nambatya, John Ssenkusu, Feiko TerKuile, Kamija Phiri, Richard Idro
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-14 (2023)
Abstract Background An estimated 300,000 babies are born with sickle cell anaemia (SCA) annually. Affected children have chronic ill health and suffer premature death. Febrile illnesses such as malaria commonly precipitate acute crises in children wi
Externí odkaz:
https://doaj.org/article/df58b96f3ad242e3be37dcec8d1b8ab5